The link between smoking and impotence: two decades of evidence.
暂无分享,去创建一个
[1] S. S. Davis,et al. Biweekly intracavernous administration of papaverine for erectile dysfunction. , 1989, The Western journal of medicine.
[2] D. L. McKay,et al. Evaluation of erectile dysfunction by dynamic infusion cavernosometry and cavernosography (DICC). Multi-institutional study. , 1993, Urology.
[3] M. Bettmann,et al. Cigarette smoking: an independent risk factor for atherosclerosis in the hypogastric-cavernous arterial bed of men with arteriogenic impotence. , 1991, The Journal of urology.
[4] W. Butler,et al. Efficacy of sildenafil citrate in prostate brachytherapy patients with erectile dysfunction. , 1999, Urology.
[5] F. B. Scott,et al. Evaluation of erectile impotence. , 1988, Urology.
[6] F. Parazzini,et al. The epidemiology of erectile dysfunction and its risk factors. , 1998, International journal of andrology.
[7] L. Horowitz,et al. Noninvasive penile arterial evaluation in 120 males with erectile dysfunction. , 1983, Urology.
[8] G. Badlani,et al. Utility of Rigiscan and papaverine in diagnosis of erectile impotence. , 1988, Urology.
[9] R. Bonnie,et al. Growing up Tobacco Free: Preventing Nicotine Addiction in Children and Youths , 1994 .
[10] L. Lantinga,et al. Risks of blood volume changes in hypogonadal men treated with testosterone enanthate for erectile impotence. , 1991, The Journal of urology.
[11] C. Begg,et al. Publication bias : a problem in interpreting medical data , 1988 .
[12] R. Shabsigh,et al. Evaluation of vasculogenic erectile impotence using penile duplex ultrasonography. , 1989, The Journal of urology.
[13] L. Kuritzky,et al. Evaluation and treatment of impotence: a pragmatic approach addressing organic and psychogenic components. , 1988, Family practice research journal.
[14] M. Hirshkowitz,et al. Nocturnal penile tumescence in cigarette smokers with erectile dysfunction. , 1992, Urology.
[15] A. Melman,et al. The epidemiology of erectile dysfunction. , 1995, The Urologic clinics of North America.
[16] R. Kirby. Fortnightly Review: Impotence: diagnosis and management of male erectile dysfunction , 1994 .
[17] R. Simes. Publication bias: the case for an international registry of clinical trials. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] J. Merenich,et al. Trial of Pentoxifylline for Diabetic Impotence , 1995, Diabetes Care.
[19] A. Melman,et al. The success of microsurgical penile revascularization in treating arteriogenic impotence. , 1993, International journal of impotence research.
[20] R. Schiavi,et al. Sexuality and aging. , 1995, The Urologic clinics of North America.
[21] S. S. Davis,et al. Impotence and Aging: Clinical and Hormonal Factors , 1988, Journal of the American Geriatrics Society.
[22] K. Hanash. Comparative results of goal oriented therapy for erectile dysfunction. , 1997, The Journal of urology.
[23] W. Steers,et al. Oral trazodone as empirical therapy for erectile dysfunction: a retrospective review. , 1995, Urology.
[24] P. Easterbrook,et al. Publication bias in clinical research , 1991, The Lancet.
[25] R. Depalma,et al. Noninvasive assessment of impotence. , 1990, The Surgical clinics of North America.
[26] T. Lin,et al. Chronic testosterone cypionate therapy in men with secondary impotence. , 1986, Fertility and sterility.
[27] N. Laird,et al. Meta-analysis in clinical trials. , 1986, Controlled clinical trials.
[28] D. Mannino,et al. Cigarette smoking: an independent risk factor for impotence? , 1994, American journal of epidemiology.
[29] H A Feldman,et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. , 1994, The Journal of urology.